Freisling, Heinz
Viallon, Vivian
Lennon, Hannah
Bagnardi, Vincenzo
Ricci, Cristian
Butterworth, Adam S.
Sweeting, Michael
Muller, David
Romieu, Isabelle
Bazelle, Pauline
Kvaskoff, Marina
Arveux, Patrick
Severi, Gianluca
Bamia, Christina
Kühn, Tilman
Kaaks, Rudolf
Bergmann, Manuela
Boeing, Heiner
Tjønneland, Anne
Olsen, Anja
Overvad, Kim
Dahm, Christina C.
Menéndez, Virginia
Agudo, Antonio
Sánchez, Maria-Jose
Amiano, Pilar
Santiuste, Carmen
Gurrea, Aurelio Barricarte
Tong, Tammy Y. N.
Schmidt, Julie A.
Tzoulaki, Ioanna
Tsilidis, Konstantinos K.
Ward, Heather
Palli, Domenico
Agnoli, Claudia
Tumino, Rosario
Ricceri, Fulvio
Panico, Salvatore
Picavet, H. Susan J.
Bakker, Marije
Monninkhof, Evelyn
Nilsson, Peter
Manjer, Jonas
Rolandsson, Olov
Thysell, Elin
Weiderpass, Elisabete
Jenab, Mazda
Riboli, Elio
Vineis, Paolo
Danesh, John
Wareham, Nick J.
Gunter, Marc J.
Ferrari, Pietro
Funding for this research was provided by:
Direction General de la Sante (GR-IARC-2003-09-12-01)
Article History
Received: 7 September 2019
Accepted: 26 November 2019
First Online: 10 January 2020
Ethics approval and consent to participate
: Informed consent was given by all study participants, and ethical approval for the entire EPIC cohort was obtained from the Institutional Review Board of the International Agency for Research on Cancer in Lyon, France, under protocol numbers SC/24/4 and SC/24/6, as well as from local ethics committees in the participating countries.
: Not applicable.
: All authors declare that they have no competing interests.